Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
作者信息
Oldenburg Catherine E, Doan Thuy
机构信息
Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
出版信息
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
Abstract
摘要
相似文献
1
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.COVID-19时代严格的随机对照试验实施
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
2
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.氯喹和羟氯喹在非洲预防或治疗 COVID-19：医疗环境中不适当的超说明书使用需谨慎。
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290.
3
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.抗 SARS-CoV-2 再利用抗病毒药物的临床试验。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01101-20.
4
Biggest COVID-19 trial tests repurposed drugs first.规模最大的新冠病毒试验首先测试重新利用的药物。
Nat Biotechnol. 2020 May;38(5):510. doi: 10.1038/s41587-020-0528-x.
5
The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.利好、弊端与骗局：当发表的内容瞬间影响新冠疫情治疗策略时
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.01127-20.
6
COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.中东地区和沙特阿拉伯的 COVID-19 疫情：预防和治疗策略。
Int J Antimicrob Agents. 2020 May;55(5):105968. doi: 10.1016/j.ijantimicag.2020.105968. Epub 2020 Apr 4.
7
COVID-19: The Need for Immunoprevention at Industrial Scale.新型冠状病毒肺炎：大规模免疫预防的必要性
Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.
8
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染：49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
9
[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].[疫情期间冠状病毒感染重症病例抗病毒治疗从经验医学到科学证据]
Med Intensiva (Engl Ed). 2020 Nov;44(8):509-512. doi: 10.1016/j.medin.2020.04.009. Epub 2020 Apr 22.
10
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.巴利昔替尼作为 COVID-19 患者对沙利鲁单抗无完全应答的补救治疗。
Infection. 2020 Oct;48(5):767-771. doi: 10.1007/s15010-020-01476-7. Epub 2020 Jul 8.
引用本文的文献
1
Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV).多西环素与羟氯喹啉联合阿奇霉素治疗新冠肺炎患者的疗效对比：撒哈拉以南非洲地区的一项开放标签随机临床试验（DOXYCOV）
Cureus. 2023 Sep 20;15(9):e45619. doi: 10.7759/cureus.45619. eCollection 2023 Sep.
2
TEG, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy.血栓弹力图、微凝块检测和血小板功能检测用于指导重症新型冠状病毒肺炎凝血病的早期管理
J Clin Med. 2021 Nov 18;10(22):5381. doi: 10.3390/jcm10225381.
3
Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials.洛匹那韦利托那韦在 COVID-19 中的疗效和安全性：一项随机对照试验的系统评价。
J Infect Public Health. 2021 Jun;14(6):740-748. doi: 10.1016/j.jiph.2021.03.015. Epub 2021 Apr 20.
4
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.HIV 相关子痫前期合并 COVID-19 孕妇的血管内皮功能障碍：综述。
Hypertens Res. 2021 Apr;44(4):386-398. doi: 10.1038/s41440-020-00604-y. Epub 2021 Jan 20.
5
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.脂肪来源的间充质基质细胞用于治疗需要机械通气的重症新型冠状病毒肺炎患者。一项概念验证研究。
EClinicalMedicine. 2020 Aug;25:100454. doi: 10.1016/j.eclinm.2020.100454. Epub 2020 Jul 10.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
3
The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.作者回应：韩国首例导致新型冠状病毒肺炎三代传播病例：洛匹那韦/利托那韦用于治疗经定量逆转录聚合酶链反应监测的新型冠状病毒肺炎
J Korean Med Sci. 2020 Feb 24;35(7):e89. doi: 10.3346/jkms.2020.35.e89.
4
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.普遍检测与治疗对南非农村地区 HIV 疫情的影响：一项 4 期、开放性标签、社区整群随机试验。
Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.
5
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.用于高效评估埃博拉病毒治疗方法的反应适应性随机化平台试验：大流行应对模型。
Clin Trials. 2016 Feb;13(1):22-30. doi: 10.1177/1740774515621721. Epub 2016 Jan 14.
Zotero 插件